Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FL8SU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,172
Award facts
- Contract value 100% obligated
- $23,172.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,172.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen auto-injectors. The order is set to be completed by November 17, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for global military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills DLA orders for a comprehensive range of medications and medical supplies supporting military and veteran healthcare systems. This specific delivery order for Zepbound—a diabetes and weight management medication—aligns with the contractor's extensive portfolio of specialty pharmaceutical deliveries across multiple therapeutic domains. As the prime contractor on this order, AmerisourceBergen leverages its established capabilities and DLA Troop Support relationship to supply essential medications to the Defense Health Agency and other government healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FL8SU?
SPE2DR26FL8SU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FL8SU worth?
The government has obligated $23,172 on SPE2DR26FL8SU.
Is contract SPE2DR26FL8SU an order under another contract?
Yes. SPE2DR26FL8SU is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL8SU competed?
The extent of competition for SPE2DR26FL8SU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award